These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7998110)

  • 21. [Immunologic and pharmacological principles for the use of immunosuppressive drugs in autoimmune diseases].
    Floersheim GL
    Schweiz Med Wochenschr; 1970 Dec; 100(52):2241-7. PubMed ID: 4946978
    [No Abstract]   [Full Text] [Related]  

  • 22. The prospects of immunosuppression in type I diabetes.
    Bach JF; Feutren G; Boitard C
    Adv Nephrol Necker Hosp; 1988; 17():321-40. PubMed ID: 3124546
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacology of chemical immunosuppression].
    Potel J; Brock N
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:339-57. PubMed ID: 5051958
    [No Abstract]   [Full Text] [Related]  

  • 24. [When are immunosuppressive agents indicated?].
    Fink U
    Med Klin; 1970 Jul; 65(29):1389. PubMed ID: 5521657
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunosuppressive treatment and its problems].
    Tsubura E
    Nihon Rinsho; 1968 Jul; 26(7):1609-15. PubMed ID: 5751013
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunosuppression and organ transplantation].
    Pichlmayr R
    Munch Med Wochenschr; 1967 Nov; 109(44):2277-83. PubMed ID: 5631653
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunosuppression in organ transplantation. New substances and therapeutic approaches].
    Wonigeit K
    Internist (Berl); 1996 Mar; 37(3):229-39. PubMed ID: 8919940
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT.
    Slavin S
    Bone Marrow Transplant; 1993 Jul; 12(1):85-8. PubMed ID: 8104072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of the effect of immunosuppression on leukocyte migration inhibition in various autoimmune diseases in children].
    Lukas A; Cesarz E; Sliwa F; Lukas W; Sychłowy A
    Pediatr Pol; 1978 Nov; 53(11):1271-5. PubMed ID: 309586
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism and role of immunological tolerance.
    Hraba T
    Monogr Allergy; 1968; 3():1-136. PubMed ID: 5761046
    [No Abstract]   [Full Text] [Related]  

  • 31. [Progress in immunosuppressive therapy and its future].
    Yamamura Y
    Nihon Rinsho; 1970 Jul; 28(7):1869-71. PubMed ID: 5466523
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunology. Gently soothing a savage immune system.
    Couzin J
    Science; 2002 Apr; 296(5567):456-8. PubMed ID: 11964457
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and basic studies on immunosuppressive agents in renal disease].
    Nihon Jinzo Gakkai Shi; 1993 May; 35(5):438-45. PubMed ID: 8361092
    [No Abstract]   [Full Text] [Related]  

  • 34. [States of immunological depression and effects of immunodepressive therapy].
    Casciani C
    Bull Soc Int Chir; 1971; 30(2):76-89. PubMed ID: 5112584
    [No Abstract]   [Full Text] [Related]  

  • 35. Resistance to anti-CD45RB-induced tolerance in NOD mice: mechanisms involved.
    Moore DJ; Huang X; Lee MK; Lian MM; Chiaccio M; Chen H; Koeberlein B; Zhong R; Markmann JF; Deng S
    Transpl Int; 2004 Jun; 17(5):261-9. PubMed ID: 15138669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autoagression and immunosuppression in dermatology. 3. Immunosuppression in autoagressive dermatoses].
    Novotný F
    Cesk Dermatol; 1973 Jan; 48(1):43-9. PubMed ID: 4687385
    [No Abstract]   [Full Text] [Related]  

  • 37. From current immunosuppressive strategies to clinical tolerance of allografts.
    Golshayan D; Buhler L; Lechler RI; Pascual M
    Transpl Int; 2007 Jan; 20(1):12-24. PubMed ID: 17181648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppression and cancer.
    Penn I; Starzl TE
    Transplant Proc; 1973 Mar; 5(1):943-7. PubMed ID: 4735211
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
    J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases].
    van den Hoogen FH; Schattenberg AV; Breedveld FC; Fibbe WE; van de Putte LB
    Ned Tijdschr Geneeskd; 1997 Oct; 141(43):2061-5. PubMed ID: 9550764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.